Evidence map›Paper›PMID 26568330›Full record

ArticleExperimental biology and medicine (Maywood, N.J.)2016

Penetration and intracellular uptake of poly(glycerol-adipate) nanoparticles into three-dimensional brain tumour cell culture models.

Weina Meng, Martin C Garnett, David A Walker, Terence L Parker

Open access · greenAbstract read
In one paragraph

Article in Experimental biology and medicine (Maywood, N.J.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Weina MengSchool of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK School of Life Sciences, University of Nottingham, Nottingham NG7 2RD, UK.
Martin C GarnettSchool of Pharmacy, University of Nottingham, Nottingham NG7 2RD, UK martin.garnett@nottingham.ac.uk.
David A WalkerQueen's Medical Centre, Nottingham NG7 2UH, UK.
Terence L ParkerSchool of Life Sciences, University of Nottingham, Nottingham NG7 2RD, UK.
University of Nottingham · GBQueen's Medical Centre · GB

Funding

Biotechnology and Biological Sciences Research Council 42/E19350Biotechnology and Biological Sciences Research Council E19350
6 · The paper itself

Abstract

Nanoparticle (NP) drug delivery systems may potentially enhance the efficacy of therapeutic agents. It is difficult to characterize many important properties of NPs in vivo and therefore attempts have been made to use realistic in vitro multicellular spheroids instead. In this paper, we have evaluated poly(glycerol-adipate) (PGA) NPs as a potential drug carrier for local brain cancer therapy. Various three-dimensional (3-D) cell culture models have been used to investigate the delivery properties of PGA NPs. Tumour cells in 3-D culture showed a much higher level of endocytic uptake of NPs than a mixed normal neonatal brain cell population. Differences in endocytic uptake of NPs in 2-D and 3-D models strongly suggest that it is very important to use in vitro 3-D cell culture models for evaluating this parameter. Tumour penetration of NPs is another important parameter which could be studied in 3-D cell models. The penetration of PGA NPs through 3-D cell culture varied between models, which will therefore require further study to develop useful and realistic in vitro models. Further use of 3-D cell culture models will be of benefit in the future development of new drug delivery systems, particularly for brain cancers which are more difficult to study in vivo.

Indexed as

AnimalsBrain NeoplasmsCell Culture TechniquesDrug CarriersHumansModels, BiologicalNanoparticlesOrgan Culture TechniquesPolyestersRats, WistarDrug CarriersPolyesterspoly(glycerol-adipate)Bionanosciencebrainpolymer nanoparticlestumor models

Identifiers

PMID26568330
PMCPMC4950476
OpenAlexW2203765632

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.